Results 201 to 210 of about 2,536,282 (288)

Roadmap of Anaphylaxis Registries Across the World

open access: yes
Clinical &Experimental Allergy, EarlyView.
Guillaume Pouessel   +8 more
wiley   +1 more source

Intravenous administration of ferric derisomaltose is associated with a higher incidence of infusion reactions than ferric carboxymaltose, and unaffected by dilution volume

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background The incidence of and risk factors for infusion‐related reactions to intravenous iron formulations remains poorly characterised. This study aimed to compare the rates of infusion reactions in patients receiving ferric derisomaltose (FDI) compared to ferric carboxymaltose (FCM), as well as across different dilutions of FDI.
Sarah Lucas   +9 more
wiley   +1 more source

Physical Symptoms and Coping Strategies With Earthquake Stress Among Adults Living in Tent Cities: A Cross‐Sectional Study

open access: yesJournal of Advanced Nursing, EarlyView.
ABSTRACT Aim This study aimed to examine the physical symptoms, coping strategies for earthquake stress and factors predicting coping strategies among adults staying in tent cities after an earthquake. Design A cross‐sectional design was conducted. Methods The study sample consisted of 706 adults residing in tent cities in three cities of earthquake ...
Ayşegül Akca   +4 more
wiley   +1 more source

Hypoglycemic timeslots after hospital discharge in patients with diabetes on multiple daily insulin injection: Dose of Insulin CHanged According to the Reported Glucose by Libre Pro (DISCHARGe study)

open access: yesJournal of Diabetes Investigation, EarlyView.
The frequency and severity of hypoglycemia peak before lunch and its nadir is 17:30 PM and increases through the post‐discharge days. ABSTRACT Introduction Insulin improves clinical outcomes in hospitalized patients; however, hypoglycemia hinders discharge transition in patients with insulin‐treated diabetes.
Manabu Saito   +5 more
wiley   +1 more source

European Guideline (EuroGuiDerm) on atopic eczema: Living update

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg   +31 more
wiley   +1 more source

Food hypersensitivity in patients suffering from atopic dermatitis and sensitization to soy.

open access: yesIndian J Dermatol, 2014
Celakovská J   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy